Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma (Q58352474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

B Ljungberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

T Rasmuson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1794-1798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

The results of radical nephrectomy for renal cell carcinoma

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Interleukin-6 and the acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Interleukin-6 and TNF alpha production in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Circadian characteristics of circulating interleukin-6 in men

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Serum levels of interleukin 6 in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Enhanced Expression of Interleukin-6 in Primary Human Renal Cell Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Interleukin-6 and renal cell cancer: production, regulation, and growth effects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Local Production of Interleukin 6 by Renal Adenocarcinoma In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

Serum acute phase reactants and prognosis in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900179-2

7 January 2021

10.1016/S0959-8049(97)00179-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470835%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference